India
· Delayed Price · Currency is INR Gujarat Themis Biosyn Statistics
Total Valuation
Gujarat Themis Biosyn has a market cap or net worth of INR 37.23 billion. The enterprise value is 37.11 billion.
| Market Cap | 37.23B |
| Enterprise Value | 37.11B |
Important Dates
The next estimated earnings date is Monday, November 11, 2024.
| Earnings Date | Nov 11, 2024 |
| Ex-Dividend Date | Jul 15, 2024 |
Share Statistics
Gujarat Themis Biosyn has 108.97 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Shares Outstanding | 108.97M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 2.99% |
| Owned by Institutions (%) | 1.15% |
| Float | 29.19M |
Valuation Ratios
The trailing PE ratio is 68.15.
| PE Ratio | 68.15 |
| Forward PE | n/a |
| PS Ratio | 23.41 |
| PB Ratio | 18.49 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 67.87 |
| EV / Sales | 23.33 |
| EV / EBITDA | 50.12 |
| EV / EBIT | 53.13 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | n/a |
| Interest Coverage | 221.16 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 24.68% |
| Revenue Per Employee | 10.00M |
| Profits Per Employee | 3.44M |
| Employee Count | 159 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +126.28% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +126.28% |
| 50-Day Moving Average | 351.28 |
| 200-Day Moving Average | 281.80 |
| Relative Strength Index (RSI) | 44.92 |
| Average Volume (20 Days) | 68,324 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Gujarat Themis Biosyn had revenue of INR 1.59 billion and earned 546.78 million in profits. Earnings per share was 5.01.
| Revenue | 1.59B |
| Gross Profit | 973.62M |
| Operating Income | 698.41M |
| Pretax Income | 733.87M |
| Net Income | 546.78M |
| EBITDA | 723.64M |
| EBIT | 698.41M |
| Earnings Per Share (EPS) | 5.01 |
Balance Sheet
The company has 145.83 million in cash and 27.68 million in debt, giving a net cash position of 118.15 million or 1.08 per share.
| Cash & Cash Equivalents | 145.83M |
| Total Debt | 27.68M |
| Net Cash | 118.15M |
| Net Cash Per Share | 1.08 |
| Equity (Book Value) | 2.01B |
| Book Value Per Share | 18.48 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 61.21%, with operating and profit margins of 43.91% and 34.38%.
| Gross Margin | 61.21% |
| Operating Margin | 43.91% |
| Pretax Margin | 46.14% |
| Profit Margin | 34.38% |
| EBITDA Margin | 45.49% |
| EBIT Margin | 43.91% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.67, which amounts to a dividend yield of 0.20%.
| Dividend Per Share | 0.67 |
| Dividend Yield | 0.20% |
| Dividend Growth (YoY) | -7.41% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.04% |
| Shareholder Yield | 0.15% |
| Earnings Yield | 1.47% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on August 9, 2024. It was a forward split with a ratio of 1.5.
| Last Split Date | Aug 9, 2024 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |